Sudeep Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
SUDEEPPHRM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudeep Pharma has filed a routine compliance certificate with NSE and BSE under Regulation 74(5) of SEBI's Depositories and Participants Regulations, 2018. The certificate was issued by the company's Registrar and Share Transfer Agent, MUFG Intime India Private Limited, for the quarter ended 31 December 2025. MUFG Intime confirmed that no dematerialisation (demat) requests were received during the quarter because all shares of the company are already held in electronic (demat) form. The filing was signed by Dimple Mehta, Company Secretary, on 8 January 2026. There is no change in shareholding structure or any corporate action involved.
This is a routine quarterly compliance filing with no material impact on the company's operations, financials, or stock price. It simply confirms that all shares are held in demat form, which is standard for a listed company.